Article

Minireview: Nanoparticles and the Immune System

Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Silver Spring, Maryland 20993, USA.
Endocrinology (Impact Factor: 4.64). 12/2009; 151(2):458-65. DOI: 10.1210/en.2009-1082
Source: PubMed

ABSTRACT Today nanotechnology is finding growing applications in industry, biology, and medicine. The clear benefits of using nanosized products in various biological and medical applications are often challenged by concerns about the lack of adequate data regarding their toxicity. One area of interest involves the interactions between nanoparticles and the components of the immune system. Nanoparticles can be engineered to either avoid immune system recognition or specifically inhibit or enhance the immune responses. We review herein reported observations on nanoparticle-mediated immunostimulation and immunosuppression, focusing on possible theories regarding how manipulation of particle physicochemical properties can influence their interaction with immune cells to attain desirable immunomodulation and avoid undesirable immunotoxicity.

Download full-text

Full-text

Available from: Africa González-Fernández, Aug 18, 2015
11 Followers
 · 
538 Views
  • Source
    • "The physico-chemical properties of NPs have proved to play an essential role in the modulation of DC immune responses during maturation, T lymphocyte proliferation and cytokine secretion. NP type [8] [18], size [29e32], shape [33], surface charge [34] and hydrophobicity [35] strongly affect the inflammatory responses of DCs and the level of cytotoxicity [29] [36]. For instance, several in vitro and in vivo studies with polymeric and metallic NPs suggest that a size lower than 200 nm enhances DC uptake, improves immunoresponse induction and the delivery of antigens [27] [30]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We have studied the effect of highly fluorescent gold nanoclusters (Au NCs) (∅< 3nm) stabilized by different ligands on the intracellular accumulation and immune response of human derived-monocyte dendritic cells (DCs). Results indicate that the high uptake efficiency of Au NCs is strongly related to their small size and to the nature of the ligand, with zwitterionic ligands being more effective than pegylated ones. Evidence from flow cytometry and microscopy demonstrate time and concentration-dependent Au NCs internalization by endocytic pathway(s) involving amorphous and laminar organelles, while maintaining their discrete size and photoluminescence properties. The uptake of zwitterionic ligand-stabilized Au NCs induced very low cytotoxicity and a strong immunosuppressive response (Th1/Treg pattern), associated with a DC maturation state. This behavior contrasts to the effect of bigger particles (∼12nm size) which induced a cytotoxic response involving Natural Killer (CD56) cells. Overall, this study stresses the critical importance of particle size and ligand type on the immunostimulation of DCs and highlights the remarkable potential of this new class of nanomaterial as a novel vaccine platform.
    Biomaterials 01/2014; accepted. DOI:10.1016/j.biomaterials.2014.11.045 · 8.31 Impact Factor
  • Source
    • "Additionally, nanocarriers are promising as the delivery systems for DNA vaccines [21]. Nanoemulsions or nanosized aerosol vaccines are also under development [22] [23]. Although many reports have shown that safe, biocompatible materials could be engineered into nanoparticles that contain drugs or vaccines, researchers are trying to develop new materials for vectors that interact specifically and predictably with cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review briefly describes the concerns of nanobiotechnology in the design and development of novel vaccines using the most known nanocarriers, including nature-made nanocarriers (such as bacterial spores, virus-like particles, exosomes, and bacteriophages), man-made nanocarriers (such as Proteosomes, liposomes, virosomes, SuperFluids, and nanobeads), and their applications in therapeutic and protective immunization, as well as their advantages and disadvantages. Here, we focus on the development of nano-based vaccines as “nanovaccines” for inducing immune systems, and the foreseeable promises and problems when compared with existing vaccines. Also, we review a potential nano-hazard for vaccines, so-called nanobacterial contamination.
    Scientia Iranica 06/2013; 54(3). DOI:10.1016/j.scient.2013.05.012 · 0.84 Impact Factor
  • Source
    • "T cells are also abundantly present in normal skin (B1 Â 10 6 cells per cm 2 ), and they display a diverse receptor repertoire (Clark et al., 2006). The possibility to exploit nanotechnology to modulate the immune system (Chen et al., 2009; Geusens et al., 2009, 2010; Jang et al., 2010a; Zolnik et al., 2010; O ¨ zbas¸-Turan and Akbug ˘a 2011) and to deliver vaccines through skin (Nasir, 2008, 2009; Fernando et al., 2010; Huang et al., 2010b) are active research area of increasing importance as recently reviewed (Prow et al., 2011a, b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: What are nanoparticles and why are they important in dermatology? These questions are addressed by highlighting recent developments in the nanotechnology field that have increased the potential for intentional and unintentional nanoparticle skin exposure. The role of environmental factors in the interaction of nanoparticles with skin and the potential mechanisms by which nanoparticles may influence skin response to environmental factors are discussed. Trends emerging from recent literature suggest that the positive benefit of engineered nanoparticles for use in cosmetics and as tools for understanding skin biology and curing skin disease outweigh potential toxicity concerns. Discoveries reported in this journal are highlighted. This review begins with a general introduction to the field of nanotechnology and nanomedicine. This is followed by a discussion of the current state of understanding of nanoparticle skin penetration and their use in three therapeutic applications. Challenges that must be overcome to derive clinical benefit from the application of nanotechnology to skin are discussed last, providing perspective on the significant opportunity that exists for future studies in investigative dermatology.
    Journal of Investigative Dermatology 01/2012; 132(3 Pt 2):964-75. DOI:10.1038/jid.2011.425 · 6.37 Impact Factor
Show more